Hjem › Kolorektal kreft › Maryland › Baltimore
Kliniske studier for Kolorektal kreft i Baltimore, MD
31 studier for Kolorektal kreft søker deltakere på steder i og rundt Baltimore (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Family Communications After Genetic Testing
RekruttererFrivillige helsepersonell ønskes velkommen
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · 8 mi unna
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- og 2 flere
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruttererFase 1
- Exelixis Clinical Site #14, Baltimore
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 3
- Greater Baltimore Medical Center, Baltimore
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
RekruttererFase 3
- MedStar Franklin Square Medical Center, Baltimore
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
RekruttererFase 3
- MedStar Franklin Square Medical Center, Baltimore
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
RekruttererFase 2/3
- Local Institution - 0262, Baltimore
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruttererFase 1
- United Theranostics, Glen Burnie · 9 mi unna
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekruttererFase 1/2
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RekruttererFase 1
- Johns Hopkins, Baltimore
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RekruttererFase 3
- Saint Agnes Hospital, Baltimore
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
RekruttererFase 1
- United Theranostics, Glen Burnie · 9 mi unna
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
RekruttererFase 1/2
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RekruttererFase 3
- Clinical Study Site, Baltimore
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
RekruttererFase 2
- Research Site, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
RekruttererFase 1
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RekruttererFase 1
- Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RekruttererFase 1
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
RekruttererFase 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RekruttererFase 2
- Johns Hopkins Hospital /ID# 275645, Baltimore
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
RekruttererFase 4
- Mercy Medical Center, Baltimore
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
Rekrutterer
- Johns Hopkins University, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
RekruttererFase 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · 9 mi unna
- United Theranostics - Chesapeake, Glen Burnie · 9 mi unna
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekruttererFase 1
- Johns Hopkins University, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
RekruttererFase 1/2
- Johns Hopkins Hospital, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruttererFase 1/2
- Johns Hopkins University, Baltimore
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
RekruttererFase 2
- Johns Hopkins SKCCC, Baltimore
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekruttererFase 1/2
- Johns Hopkins University, Baltimore
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
RekruttererFase 2
- NGM Clinical Study Site, Baltimore
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · 8 mi unna
- og 1 flere
Kolorektal kreft-studier i andre byer
- Houston, TX102 studier
- New York City, NY78 studier
- Nashville, TN69 studier
- Boston, MA63 studier
- Los Angeles, CA59 studier
- Arlington, VA52 studier
- St. Louis, MO50 studier
- San Antonio, TX46 studier
- Philadelphia, PA44 studier
- Grand Rapids, MI40 studier
- Baldwin Park, CA37 studier
- Chicago, IL34 studier
Andre studier i Baltimore
- Ikke-småcellet lungekreft60 studier
- Brystkreft47 studier
- Prostatakreft43 studier
- Lungekreft40 studier
- Kreft (alle typer)37 studier
- Pankreaskreft31 studier
- Metastatisk kreft28 studier
- Fedme26 studier
- Blærekreft24 studier
- Hjertesvikt24 studier
- Eggstokkreft22 studier
- Slag21 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.